A new, non-invasive alternative to liposuction is in the pipeline... and it could be coming to a doctor's office near you within the next 2 to 3 years.
Medicis, Inc., the Arizona-based company best known for its wrinkle fillers Restylane and Perlane, has moved into fresh territory with its recent acquisition of LipoSonix , an innovative body contouring technology that breaks down unwanted fat by directing ultrasound waves onto the skin surface. This procedure is known medically as ultrasonic lipolysis.
The LipoSonix technology is already available in Europe where it is approved and marketed for rapid, no downtime spot reduction of unwanted body fat. The initial results in Europe are promising, with patients reportedly achieving reductions of 2 to 3 inches in the circumference of treated areas after a single LipoSonix session lasting 45 to 60 minutes. Medicis CEO, Jonah Shacknai, says that his company aims to continue ongoing studies and to launch LipoSonix in the U.S. by 2011.
Another ultrasonic lipolysis treatment, UltraShape, has been available in Europe for the past three years and is also being studied for use in the U.S. But Shacknai feels that LipoSonix will have the edge, based on Canadian and European studies of Ultrashape showing that it uses significantly lower intensity ultrasound and requires multiple treatment sessions, each of longer duration. Shacknai describes LipoSonix as having "incalculable potential".
I'd agree with this, given the huge demand in the U.S. for body contouring (the market was valued at over $180 million in 2007) and the increasing numbers of patients who prefer nonsurgical treatments with little or no recovery time - as shown by the burgeoning popularity of Shacknai's flagship fillers, Restylane and Perlane, for nonsurgical face lifting. To read more about this new trend in natural-looking facial rejuvenation, check out my posts on Budget Beauty, Five Tips for Perfect Lips, New Techniques To Rejuvenate Your Eyes and Dermal Fillers.